Low Systemic Inflammation Response Index Predicts Good Prognosis in Locally Advanced Pancreatic Carcinoma Patients Treated with Concurrent Chemoradiotherapy.
Erkan TopkanHuseyin MertsoyluAhmet KucukAli Ayberk BesenAhmet SezerDuygu SezenYasemin BolukbasiUgur SelekBerrin PehlivanPublished in: Gastroenterology research and practice (2020)
Pretreatment SIRI is a novel independent prognosticator that may further enhance the conventional tumor-node-metastases staging system in a more precise prediction of the OS and PFS outcomes of LAPC patients after radical CRT.
Keyphrases
- locally advanced
- rectal cancer
- end stage renal disease
- squamous cell carcinoma
- neoadjuvant chemotherapy
- lymph node
- newly diagnosed
- radiation therapy
- ejection fraction
- chronic kidney disease
- phase ii study
- peritoneal dialysis
- prognostic factors
- type diabetes
- heart failure
- clinical trial
- skeletal muscle
- weight loss
- open label
- insulin resistance
- double blind